RhumbLine Advisers’s NextCure NXTC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-59
| Closed | -$1.12K | – | 4290 |
|
|
2024
Q2 | $1.12K | Hold |
59
| – | – | ﹤0.01% | 4232 |
|
|
2024
Q1 | $1.57K | Hold |
59
| – | – | ﹤0.01% | 4108 |
|
|
2023
Q4 | $801 | Hold |
59
| – | – | ﹤0.01% | 4166 |
|
|
2023
Q3 | $906 | Hold |
59
| – | – | ﹤0.01% | 4191 |
|
|
2023
Q2 | $1.27K | Buy |
+59
| New | +$1.27K | ﹤0.01% | 4267 |
|
|
2021
Q2 | – | Sell |
-1,555
| Closed | -$187K | – | 3073 |
|
|
2021
Q1 | $187K | Sell |
1,555
-67
| -4% | -$8.06K | ﹤0.01% | 2847 |
|
|
2020
Q4 | $212K | Buy |
1,622
+113
| +7% | +$14.8K | ﹤0.01% | 2816 |
|
|
2020
Q3 | $159K | Sell |
1,509
-242
| -14% | -$25.5K | ﹤0.01% | 2754 |
|
|
2020
Q2 | $450K | Buy |
1,751
+304
| +21% | +$78.1K | ﹤0.01% | 2398 |
|
|
2020
Q1 | $644K | Buy |
1,447
+139
| +11% | +$61.9K | ﹤0.01% | 2061 |
|
|
2019
Q4 | $884K | Buy |
+1,308
| New | +$884K | ﹤0.01% | 2139 |
|